Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy (Q38542939)

4 September 2017

1 reference

title

Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy (English)

1 reference

amyotrophic lateral sclerosis

4 September 2017

main subject

0 references

author

Giovanna Morello

series ordinal

1

0 references

Sebastiano Cavallaro

series ordinal

2

0 references

publication date

1 July 2015

1 reference

Future Medicinal Chemistry

4 September 2017

published in

1 reference

4 September 2017

volume

7

1 reference

4 September 2017

issue

10

1 reference

4 September 2017

page(s)

1335-1359

1 reference

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

4 September 2017

cites work

1 reference

Clinical trials in ALS: an overview.

21 January 2018

1 reference

Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

21 January 2018

1 reference

The paradigm of personalized therapy in oncology

21 January 2018

1 reference

The future of genomic profiling of neurological diseases using blood

21 January 2018

1 reference

Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex

21 January 2018

1 reference

Apoptotic mechanisms and the synaptic pathology of schizophrenia

21 January 2018

1 reference

Phase 2 study of sodium phenylbutyrate in ALS.

21 January 2018

1 reference

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice

21 January 2018

1 reference

Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

21 January 2018

1 reference

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

NF-kappa B as a therapeutic target in neurodegenerative diseases

21 January 2018

1 reference

Neural cell cycle dysregulation and central nervous system diseases

21 January 2018

1 reference

The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.

21 January 2018

1 reference

Cell cycle regulation of neuronal apoptosis in development and disease.

21 January 2018

1 reference

Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.

21 January 2018

1 reference

Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis-linked mutant SOD1 cultured neurons.

21 January 2018

1 reference

Extracellular matrix molecules: potential targets in pharmacotherapy.

21 January 2018

1 reference

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial

21 January 2018

1 reference

Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease

21 January 2018

1 reference

Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells

21 January 2018

1 reference

Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

Role of axonal transport in neurodegenerative diseases

21 January 2018

1 reference

The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease

21 January 2018

1 reference

Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis

21 January 2018

1 reference

Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons

21 January 2018

1 reference

Mechanism of CDK5/p25 binding by CDK inhibitors

21 January 2018

1 reference

Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel

21 January 2018

1 reference

The Role of Immune and Inflammatory Mechanisms in ALS

21 January 2018

1 reference

Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity?

21 January 2018

1 reference

Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats

21 January 2018

1 reference

Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.

21 January 2018

1 reference

Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures

21 January 2018

1 reference

Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE.

21 January 2018

1 reference

IL-10 within the CNS is necessary for CD4 T cells to mediate neuroprotection

21 January 2018

1 reference

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

21 January 2018

1 reference

Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

21 January 2018

1 reference

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

JAK2 inhibition is neuroprotective and reduces astrogliosis after quinolinic acid striatal lesion in adult mice

21 January 2018

1 reference

Neurotrophin signalling in health and disease

21 January 2018

1 reference

Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury

21 January 2018

1 reference

ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions

21 January 2018

1 reference

Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis

21 January 2018

1 reference

Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke

21 January 2018

1 reference

Suramin prevents cerebellar granule cell-death induced by dequalinium

21 January 2018

1 reference

Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs

21 January 2018

1 reference

Targeting HDACs: a promising therapy for Alzheimer's disease.

21 January 2018

1 reference

Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation.

21 January 2018

1 reference

Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis

21 January 2018

1 reference

Novel thyrotropin-releasing hormone analogs: a patent review.

21 January 2018

1 reference

Immunohistochemical study on the distribution of insulin-like growth factor I (IGF-I) receptor in the central nervous system of SOD1(G93A) mutant transgenic mice

21 January 2018

1 reference

IGF-1 receptor antagonism inhibits autophagy

21 January 2018

1 reference

Simvastatin Prevents Dopaminergic Neurodegeneration in Experimental Parkinsonian Models: The Association with Anti-Inflammatory Responses

21 January 2018

1 reference

Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis

21 January 2018

1 reference

Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors.

21 January 2018

1 reference

Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice

21 January 2018

1 reference

Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice

21 January 2018

1 reference

Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.

21 January 2018

1 reference

Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.

21 January 2018

1 reference

Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies

21 January 2018

1 reference

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

21 January 2018

1 reference

Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease

21 January 2018

1 reference

Possible GABAergic modulation in the protective effect of zolpidem in acute hypoxic stress-induced behavior alterations and oxidative damage

21 January 2018

1 reference

Glutamate, excitotoxicity and amyotrophic lateral sclerosis

21 January 2018

1 reference

Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS.

21 January 2018

1 reference

Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease

21 January 2018

1 reference

The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole.

21 January 2018

1 reference

Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically

21 January 2018

1 reference

A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis

21 January 2018

1 reference

Agonist-induced restoration of hippocampal neurogenesis and cognitive improvement in a model of cholinergic denervation

21 January 2018

1 reference

Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice

21 January 2018

1 reference

Trophic effect of olmesartan, a novel AT1R antagonist, on spinal motor neurons in vitro and in vivo

21 January 2018

1 reference

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders

21 January 2018

1 reference

Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.

21 January 2018

1 reference

Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation

21 January 2018

1 reference

Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion

21 January 2018

1 reference

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation.

21 January 2018

1 reference

Regulation of glial inflammatory mediators synthesis: possible role of endothelins

21 January 2018

1 reference

Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1.

21 January 2018

1 reference

Mitochondrial dysfunction in ALS

21 January 2018

1 reference

L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis

21 January 2018

1 reference

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

21 January 2018

1 reference

Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice

21 January 2018

1 reference

Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.

21 January 2018

1 reference

Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis

21 January 2018

1 reference

Complex genetics of amyotrophic lateral sclerosis

21 January 2018

1 reference

A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis

21 January 2018

1 reference

Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases.

21 January 2018

1 reference

Sigma-1R agonist improves motor function and motoneuron survival in ALS mice

21 January 2018

1 reference

Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole

21 January 2018

1 reference

Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration

21 January 2018

1 reference

Review: A review of the use of zonisamide in Parkinson’s disease

21 January 2018

1 reference

Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters

21 January 2018

1 reference

Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

Early-onset ALS with long-term survival associated with spastin gene mutation

21 January 2018

1 reference

Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis

21 January 2018

1 reference

Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis

21 January 2018

1 reference

Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.

21 January 2018

1 reference

Regulation of gene expression by TDP-43 and FUS/TLS in frontotemporal lobar degeneration

21 January 2018

1 reference

Rethinking ALS: the FUS about TDP-43.

21 January 2018

1 reference

Vesnarinone suppresses TNFα mRNA expression by inhibiting valosin-containing protein

21 January 2018

1 reference

Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein

21 January 2018

1 reference

Effects of vesnarinone on cytokine production and activation of murine microglia

21 January 2018

1 reference

Neuroprotective effects of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), in ischemic stroke of rats

21 January 2018

1 reference

Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase

21 January 2018

1 reference

D-amino acid oxidase controls motoneuron degeneration through D-serine

21 January 2018

1 reference

Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties

21 January 2018

1 reference

The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors

21 January 2018

1 reference

Chlorpromazine Protects Against Apoptosis Induced by Exogenous Stimuli in the Developing Rat Brain

21 January 2018

1 reference

Paraoxonase 2 (PON2) in the mouse central nervous system: A neuroprotective role?

21 January 2018

1 reference

Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats

21 January 2018

1 reference

Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/FMC.15.60

1 reference

4 September 2017

1 reference